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Multiple system atrophy (MSA) is a rare adult-onset neurodegenerative disease. Symptoms vary from autonomic dysfunction to 
Parkinsonism and cerebellar ataxia, in any combination. MSA affects many organ systems with many possible complications and 
makes perioperative management of a patient with this condition very challenging. Successful management of a patient with 
MSA posted for laparoscopic nephrectomy under general anaesthesia is reported.
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Introduction
Multiple system atrophy (MSA) is a progressive, adult-onset 
neurodegenerative disease characterised clinically by autonomic 
dysfunction, Parkinsonism, and cerebellar ataxia in any 
combination. MSA was originally thought to be three different 
diseases: Shy-Drager syndrome, striatonigral degeneration, and 
sporadic olivo-pontocerebellar atrophy. These terms are no 
longer in use, but are now considered to be components of 
MSA.1
Perioperative and postoperative haemodynamic and respiratory 
management are important considerations in these patients. We 
report successful management of a patient with MSA posted for 
laparoscopic nephrectomy under general anaesthesia.
Case report
A 62-year-old female, with controlled hypertension and diabetes 
mellitus, developed symptoms of imbalance while walking, 
frequent falling, intention tremors, incoordination, altered 
speech, swallowing difficulty, choking and coughing bouts while 
feeding, recurrent lower respiratory tract infections and loss of 
bladder control for the past two years. She was diagnosed as a 
case of MSA type C on clinical picture and investigations. She was 
treated with levodopa plus carbidopa, piracetam, citicholine and 
multivitamins. She underwent bone marrow derived 
multinuclear cell (BM MNC) transplantation for the same 
condition with little change in symptoms. She was then posted 
for a laparoscopic right partial nephrectomy due to an exophytic 
mass in the lower pole of right kidney.
Preoperatively blood pressure (BP) in both sitting and supine 
position revealed mild hypertension. Cardiac, respiratory and 
abdominal systems were normal.
Neurological examination revealed slurring of speech, tremors, 
hypotonia, hyper-reflexia, inability to walk without support, 
frequent falling, dysarthria, dysphagia, nystagmus, involuntary 
movements in all four limbs, and ataxic gait with loss of 
coordination.
Airway examination revealed adequate mouth opening, neck 
extension and Mallampati class 2.
Routine blood investigations, chest X-ray and arterial blood 
gases were normal. A pulmonary function test showed a mild 
restrictive element. Two-dimensional transthoracic echo revealed 
grade 1 diastolic dysfunction with preserved ejection fraction.
Computed tomography scan of the brain revealed patchy 
hypodensities in bilateral fronto-parietal white matter and right 
ganglio-capsular regions, suggestive of ischaemic changes.
Magnetic resonance imaging scan of the brain revealed multiple 
small ischaemic foci in both cerebral hemispheres with 
periventricular white matter neurodegenerative changes and 
diffuse cerebral atrophy.
The patient was advised to take levodopa and carbidopa, plus 
antihypertensives, on the morning of surgery with sips of water.
In the operating room, all routine monitors (five-lead ECG, non-
invasive blood pressure monitor [NIBP], pulse oximeter) were 
attached. In addition, the right internal jugular vein and right 
radial artery were cannulated for central venous and continuous 
blood pressure monitoring. Prior to induction, her pulse was 90 
beats/min and BP 150/90  mmHg, with saturation of 98% on 
room air. The patient was pre-oxygenated with 100% oxygen 
and sedated with midazolam 2 mg and fentanyl 150 μg. Induction 
was done by propofol 130 mg and atracurium 25 mg. The airway 
was secured with a 7.5 mm endotracheal tube with the help of a 
C-Mac videolaryngoscope.
The patient was placed in the left lateral position for surgery. 
Dependant parts were adequately padded. Anaesthetic depth 
was maintained with desflurane at 1 mac with O2:air at 50:50. 
Blood pressure rose to 170/100  mm of Hg on insufflation of 
carbon dioxide, which was managed by increasing desflurane 
concentration. Twenty-five minutes into the surgery, BP fell from 
140/90 mmHg to 75/35 mmHg, which was managed with fluid 
boluses and 12 mg of ephedrine. The pulse rate stayed steady at 
70 beats/min without much change even during periods of 
hypotension. The surgery lasted for two hours with 100 ml blood 
loss. The patient was given 1500 ml of Ringer’s lactate during the 
procedure with 200 ml of urine output. Pain was managed with 
fentanyl top-ups hourly and intravenous paracetamol 1gm.
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The patient was reversed and extubated after adequate attempts. 
After extubation, there was an episode of airway obstruction, 
which was manged by inserting a nasal airway. The patient 
was moved to the ICU for observation, where she was 
haemodynamically stable. She was transferred to the ward the 
next day.
Discussion
First described by Gram and Oppenheimer in 1969, MSA is 
characterised by autonomic failure, cerebellar ataxia and 
Parkinsonism in various combinations.2 Two phenotypes are 
distinguished clinically by the predominant motor symptom: the 
Parkinsonian variant (MSA-P) and the cerebellar variant (MSA-C).3
The prevalence of MSA is very low (1.94 to 4.4/100 000) with 
onset in the fifties, independent of gender.4 It is diagnosed by 
symptoms, progression and brain imaging. Treatment consists of 
management of supine hypotension, hypertension, movement 
disorders and anti-Parkinsonian medications. BM MNC is also 
being used as a modality of treatment for MSA. It exerts 
neuroprotective effects against dopaminergic neuronal death.
Disease progression is much faster in MSA than in Parkinson’s 
disease (PD) without any drug treatment that provides MSA 
patients with consistent long-term benefits.5 The clinical 
diagnosis of MSA is difficult and there are no pathognomonic 
features to discriminate the Parkinsonian variant (MSA-P) from 
PD. Hence some warning signs, also called red flags, may be 
helpful to corroborate MSA as the effective diagnosis. They are 
divided into six categories: early instability, rapid progression, 
abnormal posture, bulbar dysfunction, respiratory dysfunction, 
and emotional incontinence.6
Perioperative management of MSA remains critical. Disturbances 
in the autonomic and central nervous systems result in defective 
baroreflex and vasoconstriction of capacitance and resistance 
vessels, with an unpredictable response to vasoconstrictor agents. 
Blood loss has to be anticipated and dealt with efficiently as these 
patients do not respond with appropriate tachycardia in response 
to hypotension. Hence blood and blood products should be kept 
on standby. Also, positive pressure ventilation could lead to blood 
pressure instability due to a decrease in venous return. Autonomic 
involvement of the gut leads to higher risks of aspiration under 
anaesthesia, especially if patients have a full stomach. Involvement 
of the laryngeal muscles may lead to increased chances of 
laryngospasm and laryngeal dystonia. Interaction of opioids and 
muscle relaxants in these patients may be complicated.7 The 
presence of obstructive sleep apnoea in these patients makes the 
use of sedation difficult. Dangerous airway obstruction upon 
induction of or emergence from general anaesthesia may occur, 
but this obstruction is relatively easy to overcome by applying 
minimal positive pressure. Vocal cord abductor paralysis (VCAP) is 
well described and may cause nocturnal sudden death in patients 
with multiple system atrophy. Nocturnal stridor is the sole 
symptom of VCAP and can make the diagnosis very difficult.8 The 
chance of vocal cord paralysis is aggravated in the postoperative 
period due to insufficient depth during anaesthesia or 
unnecessary suction. Bronchoscopic intubation can be used in 
these patients, and a tracheostomy kit should be kept on standby.9 
These patients have a high incidence of postoperative ventilatory 
failure, poor recovery from general anaesthesia and ventilator 
dependence, hence ventilator back-up is advised. Despite several 
reported cases of hypotension, general anaesthesia is considered 
the gold standard in multiple system atrophy.7 We decided on 
general anaesthesia due to non-cooperation, involuntary 
movements and regional anaesthesia not being suitable for 
laparoscopic surgery. Rigidity, tremors and involuntary 
movements may make regional anaesthesia difficult to perform. 
In addition, autonomic imbalance after subarachnoid block may 
be more pronounced. Successful management of MSA patients 
under regional anaesthesia has been described. A recent article 
describes the management of a patient with MSA posted for 
transurethral resection of the prostate being managed under 
spinal anaesthesia.10
In conclusion, perioperative management of a patient with MSA 
can prove challenging for the anaesthetist, with many possible 
complications. However, these cases can be successfully 
managed and complications can be minimised with appropriate 
knowledge of the disease, thorough preoperative examination 
and tailoring the anaesthetic technique according to the extent 
of disease and type of surgery.
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